A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study

Mark H. Kirschbaum; Paul Frankel; Timothy W. Synold; Jasmine Zain; David Claxton; Joseph Tuscano; Edward M. Newman; David R. Gandara; Primo N. Lara

doi:10.1111/bjh.14333

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study

Mark H. Kirschbaum, Paul Frankel, Timothy W. Synold, Jasmine Zain, David Claxton, Joseph Tuscano, Edward M. Newman, David R. Gandara, Primo N. Lara

Hematology and Oncology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Journal	British Journal of Haematology
DOIs	https://doi.org/10.1111/bjh.14333
State	Accepted/In press - 2016

Keywords

Clinical trials
Myelodysplastic syndrome
Vascular endothelial growth factor

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.14333

Cite this

Kirschbaum, M. H., Frankel, P., Synold, T. W., Zain, J., Claxton, D., Tuscano, J., Newman, E. M., Gandara, D. R., & Lara, P. N. (Accepted/In press). A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study. British Journal of Haematology. https://doi.org/10.1111/bjh.14333

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome : A California Cancer Consortium Study. / Kirschbaum, Mark H.; Frankel, Paul; Synold, Timothy W.; Zain, Jasmine; Claxton, David; Tuscano, Joseph; Newman, Edward M.; Gandara, David R.; Lara, Primo N.

In: British Journal of Haematology, 2016.

Research output: Contribution to journal › Article › peer-review

Kirschbaum, Mark H. ; Frankel, Paul ; Synold, Timothy W. ; Zain, Jasmine ; Claxton, David ; Tuscano, Joseph ; Newman, Edward M. ; Gandara, David R. ; Lara, Primo N. / A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome : A California Cancer Consortium Study. In: British Journal of Haematology. 2016.

@article{3a9ad6cc23374cdab037c2c3b2659ee5,

title = "A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study",

keywords = "Clinical trials, Myelodysplastic syndrome, Vascular endothelial growth factor",

author = "Kirschbaum, {Mark H.} and Paul Frankel and Synold, {Timothy W.} and Jasmine Zain and David Claxton and Joseph Tuscano and Newman, {Edward M.} and Gandara, {David R.} and Lara, {Primo N.}",

year = "2016",

doi = "10.1111/bjh.14333",

language = "English (US)",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome

T2 - A California Cancer Consortium Study

AU - Kirschbaum, Mark H.

AU - Frankel, Paul

AU - Synold, Timothy W.

AU - Zain, Jasmine

AU - Claxton, David

AU - Tuscano, Joseph

AU - Newman, Edward M.

AU - Gandara, David R.

AU - Lara, Primo N.

PY - 2016

Y1 - 2016

KW - Clinical trials

KW - Myelodysplastic syndrome

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84997611337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997611337&partnerID=8YFLogxK

U2 - 10.1111/bjh.14333

DO - 10.1111/bjh.14333

M3 - Article

C2 - 27650362

AN - SCOPUS:84997611337

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this